31
Views
0
CrossRef citations to date
0
Altmetric
Research Article

High-dose Proton-Pump Inhibitors as a Diagnostic Test of Gastro-oesophageal Reflux Disease in Endoscopic-negative Patients

Pages 806-810 | Published online: 08 Jul 2009

References

  • Galmiche JP, Letessier E, Scarpignato C. Fortnightly review: treatment of gastro-oesophageal reflux disease in adults. BMJ 1998;316:1720–3.
  • Jamieson JR, Stein HJ, DeMeester TR, Bonavina L, Schwizer W, Hinder RA, et al. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 1992;87:1102–11.
  • Kahrilas PJ, Quigley EMM. American gastrointestinal Association Medical Position Statement: guidelines on the use of esophageal pH recording. Gastroenterology 1996;110:1981–96.
  • Fass R, Hell R, Sampliner RE, Pulliam G, Graver E, Hartz V, et al. Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities. Dig Dis Sci 1999;44:2263–9.
  • Johnsson F, Weywadt L, Solhaug J-H, Hernqvist H, Bengtsson L. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol 1998;33:15–20.
  • Fass R, Fennerty MB, Ofman JJ, Gralnek IM, Johnson C, Camargo E, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 1998;115:42–9.
  • Fass R, Ofman JJ, Gralnek IM, Johnson C, Camargo E, Sampliner RE, et al. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med 1999;159:2161–8.
  • Bate CM, Riley SA, Chapman RW, Durnin AT, Taylor MD. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1999;13:59–66.
  • Thoring M, Hedenstrom H, Eriksson LS. Rapid effect of lansoprazole on intragastric pH: a crossover comparison with omeprazole. Scand J Gastroenterol 1999;34:341–5.
  • Savary M, Miller G. The esophagus: handbook and atlas of endoscopy. Solothurn: Verlag Gassmann AG; 1978.
  • Nyren O, Adami HO, Bates S, Bergstrom R, Gustavsson S, Loof L, et al. Self-rating of pain in nonulcer dyspepsia. A methodological study comparing a new fixed-point scale and the visual analogue scale. J Clin Gastroenterol 1987;9:408–14.
  • Wiener GJ, Morgan TM, Copper JB, Wu WC, Castell DO, Sinclair JW, et al. Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci 1988;33:1127–33.
  • Richter JE, Laurence A, Bradley LA, DeMeester TR, Wallace C. Normal 24-h ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci 1992; 37:849–56.
  • DeMeester TR, Peters JH, Bremner CG, Chandrasoma P. Biology of gastroesophageal reflux disease: pathophysiology relating to medical and surgical treatment. Annu Rev Med 1999; 50:469–506.
  • Hunt RH. Importance of pH control in the management of GERD. Arch Intern Med.1999;159:649–57.
  • Nehra D, Howell P, Pye JK, Beynon J. Assessment of combined bile acid and pH profiles using an automated sampling device in gastro-oesophageal reflux disease. Br J Surg 1998;85:134–7.
  • Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Festen HP, Jansen EH, Tuynman HA, et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol 1997;92: 1997–2000.
  • Fass R, Sampliner RE, Mackel C, McGee D, Rappaport W. Age- and gender-related differences in 24-hour esophageal pH monitoring of normal subjects. Dig Dis Sci 1993;38: 1926–8.
  • Rodriguez-Stanley S, Robinson M, Earnest DL, Greenwood-Van Meerveld B, Miner PB Jr. Esophageal hypersensitivity may be a major cause of heartburn. Am J Gastroenterol 1999;94: 628–31.
  • Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ, et al. An evidence-based appraisal of reflux disease management—the Genval Workshop Report. Gut 1999;44:1–16.
  • Fallone CA, Barkun AN, Gottke MU, Best LM, Loo VG, Veldhuyzen van Zanten S, et al. Association of Helicobacter pylori genotype with gastroesophageal reflux disease and other upper gastrointestinal diseases. J Gastroenterol 2000;95:659–69.
  • Schindlbeck NE, Klauser AG, Voderholzer WA, Müller-Lissner SA. Empiric therapy for gastroesophageal reflux disease. Arch Intern Med 1995;155:1808–12.
  • Castell DO, Katz PO. The acid suppression test for unexplained chest pain. Gastroenterology 1998;115:222–4.
  • Tolman KG, Sanders SW, Buchi KN, Karol MD, Jennings DE, Ringham GL. The effects of oral doses of lansoprazole and omeprazole on gastric pH. J Clin Gastroenterol 1997;24:65–70.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.